Where is the place for rituximab in the treatment of B-cell non-Hodgkin lymphoma (B-NHL) of children and adolescents?

被引:0
|
作者
Patte, C. [1 ]
机构
[1] Inst Gustave Roussy, Dept Pediat, Villejuif, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:110 / 110
页数:1
相关论文
共 50 条
  • [1] Outcome of Relapse in Children/Adolescents with B-Cell Non-Hodgkin Lymphoma (B-NHL) and Mature Acute Leukemia (B-AL) Treated in the Rituximab (R) Era
    Rigaud, C.
    Auperin, A.
    Jourdain, A.
    Schmitt, C.
    Paillard, C.
    Couec, M. L.
    Aladjidi, N.
    Gandemer, V.
    Lambilliote, A.
    Plat, G.
    Michon, J.
    Leblanc, T.
    Patte, C.
    Minard-Colin, V.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S36 - S36
  • [2] Phase I study of bendamustine combined with rituximab in relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (B-NHL)
    Taniwaki, M.
    Ogura, M.
    Matsumoto, Y.
    Uchida, T.
    Ohmachi, K.
    Ando, K.
    Watanabe, T.
    Tobinai, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Phase II study of oral Fludarabine (FAMP) in combination with rituximab in indolent B-cell non-hodgkin lymphoma (B-NHL)
    Ishizawa, Kenichi
    Tobinai, Kensei
    Ogura, Michinori
    Itoh, Kuniaki
    Aorishima, Yasuo
    Ando, Kiyoshi
    Yamamoto, Joji
    Watanabe, Takashi
    Uchida, Toshiki
    Nakata, Masanobu
    Hayashi, Masaki
    Hotta, Tomomitsu
    BLOOD, 2007, 110 (11) : 387A - 387A
  • [4] Safety, Efficacy and Rituximab Levels Following Chemoimmunotherapy (Rituximab plus FAB Chemotherapy) in Children and Adolescents with Mature B-Cell Non-Hodgkin Lymphoma (B-NHL): A Children's Oncology Group Report
    Cairo, Mitchell S.
    Lynch, James
    Harrison, Lauren
    van de Ven, Carmella
    Gross, Thomas
    Shiramizu, Bruce
    Sanger, Warren
    Perkins, Sherrie L.
    Goldman, Stanton
    BLOOD, 2008, 112 (11) : 310 - 310
  • [5] TANDEM AUTOLOGOUS ALLOGENEIC STEM CELL TRANSPLANTATION IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH RELAPSED/REFRACTORY MATURE B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
    Gardenswartz, A.
    Mehta, B.
    El-Mallawany, N.
    van de Ven, C.
    Hochberg, J.
    Flower, A.
    Morris, E.
    Harrison, L.
    Basso, J.
    Gerard, P.
    Ayello, J.
    Baxter-Lowe, L. A.
    Cairo, M. S.
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [6] Integrated population modeling of loncastuximab tesirine (Lonca) exposure in B-cell non-Hodgkin lymphoma (B-NHL).
    Solh, Melhem
    Alderuccio, Juan Pablo
    Stathis, Anastasios
    Ungar, David
    Liao, Sam
    Khouri, Lisa
    Zhang, Xiaoyan
    Boni, Joseph
    CANCER RESEARCH, 2021, 81 (13)
  • [7] Overt B-cell non-Hodgkin's lymphoma (B-NHL): Role of hepatitis C virus (HCV).
    Germanidis, G
    Haioun, C
    Gaulard, P
    Reyes, F
    Dhumeaux, D
    Pawlotsky, JM
    HEPATOLOGY, 1999, 30 (04) : 605A - 605A
  • [8] Overt B-cell non-Hodgkin's lymphoma (B-NHL):: Role of hepatitis C virus (HCV)
    Germanidis, G
    Haioun, C
    Gaulard, P
    Castéra, L
    Reyes, F
    Dhumeaux, D
    Pawlotsky, JM
    JOURNAL OF HEPATOLOGY, 2000, 32 : 99 - 99
  • [9] Low level of cerebrospinal fluid (CSF) rituximab (RTX) following intravenous rituximab in children, adolescents and young adults (CAYA) with de novo mature B-cell Non-Hodgkin lymphoma (B-NHL)
    Barth, Matthew J.
    Chu, Yaya
    Goldman, Stanton C.
    Hochberg, Jessica
    Oesterheld, Javier
    Heym, Kenneth
    Harrison, Lauren
    Mahanti, Harshini
    Flowers, Allyson
    Basso, Jackie
    Cairo, Mitchell S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 47 - 47
  • [10] Chromosomal Alterations in Gene Expression-Defined Pediatric Aggressive B-Cell Non-Hodgkin Lymphoma (B-NHL)
    Deffenbacher, Karen E.
    Iqbal, Javeed
    Liu, Zhongfeng
    Perkins, Sherrie L.
    Lim, Megan S.
    Fu, Kai
    Shen, Yulei
    Staudt, Louis M.
    Rimsza, Lisa M.
    Jaffe, Elaine S.
    Rosenwald, Andreas
    Ott, German
    Delabie, Jan
    Campo, Elias
    Gascoyne, Randy D.
    Weisenburger, Dennis D.
    Greiner, Timothy C.
    Gross, Thomas
    Chan, Wing C.
    BLOOD, 2009, 114 (22) : 1142 - 1142